Therapeutically reducing Inpp5f expression or biologically inhibiting its activity would be a promising strategy in protecting cardiac function in the context of diabetes, especially under the context of hyperglycemia and hyperlipidemia. Here, INPP5F is linked to diabetes mellitus.